Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Infectious Disease PHGKB

Specific PHGKB|Infectious Diseases PHGKB|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last Posted: Jun 28, 2024
spot light Spotlight

Targeted next-generation sequencing (NGS) to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis
(Posted May 26, 2024 11AM)

From the abstract: "Targeted NGS is highly sensitive and specific for detecting drug resistance across panels of tuberculosis drugs and can be performed directly on clinical samples. There is a paucity of data on performance for some currently recommended drugs. The barriers preventing the use of targeted NGS to diagnose drug-resistant tuberculosis in high-burden countries need to be addressed. "

Evolution of Gene Therapy for Inborn Errors of Immunity
(Posted May 22, 2024 2PM)

From the article: "Inborn errors of immunity comprise more than 500 monogenic defects that predispose affected individuals to life-threatening infections, autoimmunity, and lymphoproliferation. The diagnosis and treatment of inborn errors of immunity have significantly evolved in the past few decades. Currently, a hematopoietic stem cell transplant (HSCT) is the definitive treatment of many IEIs. However, an HSCT carries risks, such as graft-vs-host disease and decreased survival rates in the absence of an HLA-matched donor. Gene therapy (GT) offers a promising alternative by targeting and correcting specific genetic mutations. "

Cancer mRNA vaccines: clinical advances and future opportunities
(Posted May 20, 2024 10AM)

From the abstract: "Thus far, no mRNA-based cancer vaccines have received regulatory approval, although several phase I–II trials have yielded promising results, including in historically poorly immunogenic tumours. Furthermore, many early phase trials testing a wide range of vaccine designs are currently ongoing. In this Review, we describe the advantages of cancer mRNA vaccines and advances in clinical trials using both cell-based and nanoparticle-based delivery methods, with discussions of future combinations and iterations that might optimize the activity of these agents. "

High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response
(Posted May 14, 2024 3PM)

From the abstract: " How human genetic variation contributes to vaccine effectiveness in infants is unclear, and data are limited on these relationships in populations with African ancestries. We undertook genetic analyses of vaccine antibody responses in infants from Uganda (n=1391), Burkina Faso (n=353) and South Africa (n=755), identifying associations between human leukocyte antigen (HLA) and antibody response for five of eight tested antigens spanning pertussis, diphtheria and hepatitis B vaccines. In addition, through HLA typing 1,702 individuals from 11 populations of African ancestry derived predominantly from the 1000 Genomes Project, we constructed an imputation resource, fine-mapping class II HLA-DR and DQ associations explaining up to 10% of antibody response variance in our infant cohorts. "


news Latest News and Publications
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity. External Web Site Icon
Chang-Rabley Emma, et al. Vaccines 2024 0 0. (6)
Development of the second version of Global Prediction System for Epidemiological Pandemic. External Web Site Icon
Huang Jianping, et al. Fundamental research 2024 0 0. (3) 516-526
Estimating the COVID-19 prevalence from wastewater. External Web Site Icon
Mohring Jan, et al. Scientific reports 2024 0 0. (1) 14384
High-resolution short-term prediction of the COVID-19 epidemic based on spatial-temporal model modified by historical meteorological data. External Web Site Icon
Chen Bin, et al. Fundamental research 2024 0 0. (3) 527-539
Monitoring SARS-CoV-2 RNA in wastewater from a shared septic system and sub-sewershed sites to expand COVID-19 disease surveillance. External Web Site Icon
Pasha A B Tanvir, et al. Journal of water and health 2024 0 0. (6) 978-992
Nearly Instantaneous Time-Varying Reproduction Number for Contagious Diseases-a Direct Approach Based on Nonlinear Regression. External Web Site Icon
ŠaltytE Benth JuratE, et al. Journal of computational biology : a journal of computational molecular cell biology 2024 0 0.
The Human Genetic Differences in the Outcomes of mRNA Vaccination against COVID-19: A Prospective Cohort Study. External Web Site Icon
Ryu Ha-Eun, et al. Vaccines 2024 0 0. (6)
Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients. External Web Site Icon
Gupta Sudhir, et al. Pathogens (Basel, Switzerland) 2024 0 0. (6)
Transmission Patterns of Co-Circulation of Omicron Sub-Lineages in Hong Kong SAR, China, a City with Rigorous Social Distancing Measures, in 2022. External Web Site Icon
Ning Chow et al. Viruses 2024 6 (6)
Comparing full variation profile analysis with the conventional consensus method in SARS-CoV-2 phylogeny. External Web Site Icon
Regina Nóra Fiam et al. Brief Bioinform 2024 6 (4)

More

Content Summary

Common Type

myPHGKB

Quick Links


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP